Status:
NOT_YET_RECRUITING
Glofitamab in Real Life
Lead Sponsor:
The Lymphoma Academic Research Organisation
Conditions:
Large B-cell Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
To date, more than 300 patients have been treated with Glofitamab in the Expanded Access Programme (EAP) in France. In this study, it is proposed to perform a retrospective analysis of some of these p...
Eligibility Criteria
Inclusion
- patient enrolled in the French Glofitamab EAP for R/R DLBCL before 2024 November 1st, 2024
- patient who received at least Obinutuzumab pretreatment and one infusion of Glofitamab
- adult patient
- patient who is informed of the study and who did not oppose to their data collection
Exclusion
- none
Key Trial Info
Start Date :
August 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06994169
Start Date
August 1 2025
End Date
November 30 2026
Last Update
May 29 2025
Active Locations (30)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Victor Dupouy
Argenteuil, France, 95100
2
CH d'Avignon - Hôpital Henri Dufaut
Avignon, France, 84000
3
CH de la Côte Basque
Bayonne, France
4
CHRU Besançon - Hôpital Minjoz
Besançon, France